For adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well

Results

RINVOQ

The proof is in the clinical studies

7 out of 10

More RINVOQ results
that won't back down

RAPID
SYMPTOM RELIEF

In Study 1 and Study 2 combined, 62% of people taking RINVOQ 45 mg (n=660) reported less frequent bowel movements and bloody stools compared to 27% of people taking placebo (n=328) at Week 2

SYMPTOM RELIEF

In Study 2, 75% of people taking RINVOQ 45 mg (n=341) experienced symptom relief compared to 25% of people taking placebo (n=174) at Week 8

SYMPTOM RELIEF

At week 8, ~73% of people taking RINVOQ 45 mg (n=319) in study 1 and 75% of people taking RINVOQ 45 mg (n=341) in study 2 experienced symptom relief, compared to 27% of people taking placebo in study 1 (n=154) and 25% of people taking placebo in study 2 (n=174)

*Based on the frequency of bowel movements, the amount of bloody stools, and the visible appearance of the colon lining.

VISIBLE COLON
LINING REPAIR

In Study 2, 44% of people taking RINVOQ 45 mg (n=341) experienced a visible improvement of the colon lining compared to 8% of people taking placebo (n=174) at Week 8

VISIBLE COLON
LINING REPAIR

At week 8, 36% of people taking RINVOQ 45 mg (n=319) in study 1 and 44% of people taking RINVOQ 45 mg (n=341) in study 2 experienced a visible improvement of the colon lining, compared to 7% of people taking placebo in study 1 (n=154) and 8% of people taking placebo in study 2 (n=174)

Areas that were visually assessed may not represent repair of the entire colon lining.

LASTING
STEROID-FREE REMISSION

In study 3, of those who achieved remission at week 8, 68% of people taking RINVOQ 30 mg (n=58) and 57% of people taking RINVOQ 15 mg (n=47) achieved steroid-free remission at one year, compared to 22% of people taking placebo (n=54)

VISIBLE COLON
LINING REPAIR

In Study 3, 62% of people taking RINVOQ 30 mg (n=154) and 49% of people taking RINVOQ 15 mg (n=148) experienced a visible improvement of the colon lining at one year, compared to 15% of people taking placebo (n=149)

Areas that were visually assessed may not represent repair of the entire colon lining.

REMISSION AT 1 YEAR:

42% of people taking RINVOQ 15 mg and 52% of people taking RINVOQ 30 mg achieved remission, compared to 12% of people taking placebo

Once-daily RINVOQ can help people with UC get:

Rapid relief from UC symptoms* in as early as 2 weeks

*Based on the frequency of bowel movements and the amount of bloody stools. 

No bowel urgency and no abdominal pain in 8 weeks

Steroid-free remission at 1 year

Visible colon lining repair even at 1 year

Areas that were visually assessed may not represent repair of the entire colon lining.

See the science
behind RINVOQ

Learn how RINVOQ works.

Now that my UC
symptoms are in check, I don’t have to worry about finding the nearest restroom.”

—JACORRIAN, moderate to severe UC patient

Make once-daily RINVOQ part of your routine.
Get the facts about
Taking RINVOQ for UC >


Take charge: More topics for you

Frequently asked questions about RINVOQ

Get answers to some of the most commonly asked questions about RINVOQ.

Meet real RINVOQ patients

Find out what patients have to say about their experience with UC and RINVOQ.